Guidelines

P1.10 Immunoglobulin and T-cell receptor gene analysis by next-generation sequencing

January 2016
P1.11 Retrospective Chart Review of Hospitalisations and Costs Associated with the Treatment of Adults with Philadelphia-negative (-) B-precursor Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL) in Belgium

January 2016
P1.12 Identification of clinical and biological parameters predictive of chemotherapy completion and two-year overall survival in clinically fit older patients with haematological malignancies

January 2016
P1.13 Blocking S100A9 interactions in the Multiple Myeloma bone marrow environment reduces angiogenesis and tumor growth

January 2016
P1.14 Molecular biology vs. Statistics: A patient with concomitantly occurring CLL and MPN

January 2016
P1.15 Multiple Myeloma in Black Africans, clinical and biological characteristics

January 2016
P1.16 Cutaneous involvement and linear IgA dermatosis in a patient with angioimmunoblastic T-cell lymphoma

January 2016
P2.01 Evaluation of the Red Blood Cell Advanced Software Application on the CellaVision DM96

January 2016
P2.02 Belgian consensus on the diagnosis and management of Paroxysmal Nocturnal Hemoglobinuria

January 2016
P2.03 Evaluation of the Red Blood Cell Advanced Software Application on the CellaVision DM96

January 2016

Top